{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:18:02Z","timestamp":1761715082412,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.pcd.2017.02.001","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T12:49:50Z","timestamp":1487854190000},"page":"373-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Trends in breast cancer incidence among women with type-2 diabetes in British general practice"],"prefix":"10.1016","volume":"11","author":[{"given":"Heleen K.","family":"Bronsveld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.H.L.","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.H.","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthonius","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjanka K.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie L.","family":"De Bruin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2017.02.001_bib0005","first-page":"991","article-title":"Diabetes and cancer II: role of diabetes medications and influence of shared risk factors","volume":"23","author":"Onitilo","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.pcd.2017.02.001_bib0010","unstructured":"Diabetes Atlas Internal Diabetes Federation, 7th ed., 2015."},{"key":"10.1016\/j.pcd.2017.02.001_bib0015","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(11)61351-2","article-title":"Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis","volume":"378","author":"Forouzanfar","year":"2011","journal-title":"Lancet (London, England)"},{"year":"2012","series-title":"International Agency for Reserarch on Cancer, Section of Cancer Surveillance, Breast","author":"GLOBOCAN","key":"10.1016\/j.pcd.2017.02.001_bib0020"},{"year":"2017","series-title":"Cancer Research UK","author":"Breast cancer incidence statistics","key":"10.1016\/j.pcd.2017.02.001_bib0025"},{"key":"10.1016\/j.pcd.2017.02.001_bib0030","unstructured":"Diabetes Atlas Internal Diabetes Federation, 6th ed., 2013."},{"key":"10.1016\/j.pcd.2017.02.001_bib0035","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants","volume":"387","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.pcd.2017.02.001_bib0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pcd.2016.05.003","article-title":"Trends in diabetes incidence from 1992 to 2015 and projections for 2024: a Portuguese General Practitioner\u2019s Network study","volume":"10","author":"de Sousa-Uva","year":"2016","journal-title":"Prim. Care Diabetes"},{"year":"2007","series-title":"Diabetes in the United Kindgom: Analysis of QRESEARCH Data","author":"Hippisley-Cox","key":"10.1016\/j.pcd.2017.02.001_bib0045"},{"key":"10.1016\/j.pcd.2017.02.001_bib0050","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2174\/15748863113086660071","article-title":"CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants\u2014a systematic review and a meta-analysis","volume":"8","author":"Starup-Linde","year":"2013","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.pcd.2017.02.001_bib0055","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ijc.22717","article-title":"Diabetes mellitus and risk of breast cancer: a meta-analysis","volume":"121","author":"Larsson","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.pcd.2017.02.001_bib0060","doi-asserted-by":"crossref","first-page":"s823","DOI":"10.1093\/ajcn\/86.3.823S","article-title":"Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence","volume":"86","author":"Xue","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.pcd.2017.02.001_bib0065","first-page":"1061","article-title":"Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature","volume":"12","author":"Liao","year":"2011","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.pcd.2017.02.001_bib0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1200\/JCO.2009.27.3011","article-title":"Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis","volume":"29","author":"Peairs","year":"2011","journal-title":"J. Clin. Oncol."},{"year":"1994","series-title":"Prevention of Diabetes Mellitus. Report of a WHO study Group","author":"World Health Organisation","key":"10.1016\/j.pcd.2017.02.001_bib0075"},{"key":"10.1016\/j.pcd.2017.02.001_bib0080","doi-asserted-by":"crossref","first-page":"R225","DOI":"10.1530\/ERC-12-0203","article-title":"The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression","volume":"19","author":"Rose","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.pcd.2017.02.001_bib0085","doi-asserted-by":"crossref","first-page":"e51446","DOI":"10.1371\/journal.pone.0051446","article-title":"Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis","volume":"7","author":"Cheraghi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pcd.2017.02.001_bib0090","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.pcd.2017.02.001_bib0095","article-title":"Is the CPRD GOLD population comparable to the U.K. population?","author":"Campbell","year":"2013","journal-title":"29th ICPE Pharmacoepidemiology and Drug Savety"},{"key":"10.1016\/j.pcd.2017.02.001_bib0100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","article-title":"Validation and validity of diagnoses in the General Practice Research Database: a systematic review","volume":"69","author":"Herrett","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pcd.2017.02.001_bib0105","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.3399\/bjgp10X483562","article-title":"Validity of diagnostic coding within the General Practice Research Database: a systematic review","volume":"60","author":"Khan","year":"2010","journal-title":"Br. J. Gen. Practice"},{"key":"10.1016\/j.pcd.2017.02.001_bib0110","doi-asserted-by":"crossref","first-page":"b5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes","volume":"340","author":"Levesque","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.pcd.2017.02.001_bib0115","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/pds.3374","article-title":"Cancer recording and mortality in the General Practice Research Database and linked cancer registries","volume":"22","author":"Boggon","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"year":"2017","series-title":"Eurostat","author":"European Standard Population","key":"10.1016\/j.pcd.2017.02.001_bib0120"},{"year":"1979","series-title":"Epidemiologic Analysis with a Programmable Calculator","author":"Rothman","key":"10.1016\/j.pcd.2017.02.001_bib0125"},{"key":"10.1016\/j.pcd.2017.02.001_bib0130","unstructured":"P. Boyle, D.M. Parkin, Chapter 11. Statistical Methods for Registries, in: International Agency for Research on Cancer, pp. 135\u2013136 (age-standardized rate), 138\u2013139 (age-standardized rate ratio)."},{"key":"10.1016\/j.pcd.2017.02.001_bib0135","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2337\/dc14-1996","article-title":"Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation","volume":"38","author":"Harding","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2017.02.001_bib0140","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/1471-2407-11-401","article-title":"An investigation of the apparent breast cancer epidemic in France: screening and incidence trends in birth cohorts","volume":"11","author":"Junod","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pcd.2017.02.001_bib0145","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0140-6736(12)61611-0","article-title":"The benefits and harms of breast cancer screening: an independent review","volume":"380","author":"Independent UK Panel on Breast Cancer Screening","year":"2012","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.pcd.2017.02.001_bib0150","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12885-015-1296-8","article-title":"Body mass index and participation in organized mammographic screening: a prospective cohort study","volume":"15","author":"Hellmann","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pcd.2017.02.001_bib0155","unstructured":"J.B. Austoker V., A. Berrington, R.G. Blanks, N.E. Day, T.J. Day, I.O. Ellis, Screening for breast cancer in England: past and future, NHSBSP Publication, 61 (2006)."},{"issue":"100","key":"10.1016\/j.pcd.2017.02.001_bib0160","article-title":"Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence","volume":"17","author":"Bronsveld","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.pcd.2017.02.001_bib0165","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1158\/1940-6207.CAPR-13-0424","article-title":"Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders","volume":"7","author":"Gandini","year":"2014","journal-title":"Cancer Prev. Res. (Phila. PA)"},{"key":"10.1016\/j.pcd.2017.02.001_bib0170","unstructured":"KWF kanker bestrijding, Kanker in Nederland. Trends, prognoses en implicaties voor zorgvraag. Data from IKZ and RIVM, (2004) 218."},{"year":"2017","series-title":"Quality and Outcomes Framework for 2012\/13; Guidance for PCOs and Practices. NHS Employers","key":"10.1016\/j.pcd.2017.02.001_bib0175"},{"year":"2017","series-title":"Diabetes: Facts and Stats. DIABETES UK","key":"10.1016\/j.pcd.2017.02.001_bib0180"}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991817300244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991817300244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:56:11Z","timestamp":1761695771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991817300244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1751991817300244"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2017.02.001","relation":{},"ISSN":["1751-9918"],"issn-type":[{"type":"print","value":"1751-9918"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in breast cancer incidence among women with type-2 diabetes in British general practice","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2017.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}